3 results
Approved WMOCompleted
The aim is to study the effectiveness of arthrocentesis as initial treatment of arthropathy as compared to usual care.
Approved WMORecruiting
The primary objective of this study is to assess whether abelacimab is non-inferior to dalteparin for preventing VTE recurrence through 6 monthspost randomization in patients with GI or GU cancer and recently diagnosed VTE. If non-inferiority is…
Approved WMORecruiting
The primary objective of this study is to assess whether abelacimab is non-inferior to apixaban for preventing VTE recurrence at 6 months postrandomization in patients with cancer and recently diagnosed VTE. If noninferiority is demonstrated, then…